Skip to main content

Anti-Kv1.6 K+ channel [K19/36R] in Immunohistochemistry (Rat)

Addgene #184211

Data Submitted By
James Trimmer
Lab Name
James Trimmer, UC Davis
Submission Date
October 09, 2024
Publication Date
October 18, 2024 (modified November 21, 2024)
Abstract
Experimental results for Anti-Kv1.6 K+ channel [K19/36R] (Addgene #184211) in an immunohistochemistry assay with rat brain samples.
Caption: Free-floating rat brain sections were fixed and labeled with purified, recombinant Anti-Kv1.6 K+ channel [K19/36R] or TC Supernatant from NeuroMab clone K19/36. The labeling patterns were compared between the two antibodies.
Image attribution: James Trimmer, UC Davis

This report is made available under the Creative Commons Attribution 4.0 International License.

Antibodies Used
Anti-Kv1.6 K+ channel [K19/36R]
Addgene #184211
Mix of biotinylated goat anti-mouse IgG2a
Jackson ImmunoResearch Labs #115-065-205, 115-065-206, 115-065-207

Materials & Methods

Sample

Species
Rat
Cell / Tissue Type
Brain
Preparation
Free-floating

Buffer

Name
PBS
pH
7.4

Fixative

Fixative
Formaldehyde/Paraformaldehyde

Permeabilization / Delipidation

Agent
PBS containing 1:2000 avidin and 0.5% Triton X-100
Time
45 min
Temperature
Room Temperature

Blocking

Agent
Serum
Concentration
0.5% w/v
Time
45 min
Temperature
Room Temperature

Primary Antibody

Name
Anti-Kv1.6 K+ channel [K19/36R]
Source
Addgene
Catalog Number
184211
Species
Mouse
Gene / Target
Kcna6
Concentration
1 µg/mL
Time
Overnight
Temperature
4 ˚C
View in Addgene Catalog

Secondary Antibody

Name
Mix of biotinylated goat anti-mouse IgG2a
Source
Jackson ImmunoResearch Labs
Catalog Number
115-065-205, 115-065-206, 115-065-207
Concentration
1 µg/mL
Time
60 min
Temperature
Room Temperature

Additional Information

Protocol
Trimmer lab immunohistochemistry protocol (Link opens in a new window)
Controls
The labeling pattern was compared to the NeuroMab K19/36.

Results

Result
Pass (The antibody worked under these conditions)
Describe Results
Labeling pattern was compared and found to be equivalent to the NeuroMab K19/36.